Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Aisha Walker, PhD
Researcher Assistant Professor of Medicine
Division of Pulmonary,
Allergy and Critical Care Medicine
Vascular Medicine Institute
University of Pittsburgh
E1226-0A BST
200 Lothrop Street
Pittsburgh, Pennsylvania, United States
Dr. Walker is a Research Assistant Professor in the Vascular Medicine Institute at University of Pittsburgh. Dr. Walker is currently a Sickle Cell Scholar at Pitt. Her basic and translational research projects continue to investigate mechanisms related to pharmacologic therapies for sickle cell disease.
Dr. Walker’s primary research goal is to identify novel therapeutic strategies for the treatment of sickle cell disease (SCD). Her current projects are focused on identifying cellular and molecular modulators that mediate efficacy and toxicity of hydroxyurea, which is currently the only FDA approved drug for SCD. Dr. Walker’s work was the first to identify specific cell membrane transporters and microRNAs associated with the pharmacokinetics and clinical outcomes of hydroxyurea.
Related Content
-
More Curative Bone Marrow Transplants are Successful When Patients Given Double the Radiation Beforehand, Study SaysThe success rate of bone marrow transpla...
-
Griffin P. Rodgers, MD, MACPDr. Griffin Rodgers, Director of the Nat...
-
Sickle Cell Disease Research Shows Progress in Preventing Related Complications and DeathStudies aim to limit pain crises, preven...
-
Webinar Series: Sickle Cell Science: Path to Progress – Sickle Cell Disease Care in the Emergency Department: ...To commemorate Sickle Cell Awareness Mon...
-
Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell diseaseTransfusional iron overload represents a...
-
Efficacy and safety of ledipasvir/sofosbuvir for the treatment of chronic hepatitis C in persons with sickle cell di...Patients with sickle cell disease are at...
-
Columbia University Medical CenterThe Division of Pediatric Hematology at ...